*(HealthDay News via Yahoo News) — Researchers studying the link between diabetes and a hormone that affects your so-called “body clock” have identified a genetic mutation in the receptor for the hormone, melatonin, that may to boost the risk of the disease.
The finding could help improve assessment of a person’s diabetes risk and could also lead to the development of personalized treatments, according to the study published in the Jan. 29 online edition of the journal Nature Genetics.
The research team from Imperial College London found that people who have rare genetic mutations in the receptor for melatonin have a greatly increased risk for type 2 diabetes.
Melatonin controls the body’s sleep-wake cycle. A previous study found that people with common variations in the gene for the melatonin receptor MT2 have a slightly increased risk for type 2 diabetes.
This new study discovered that having any of four rare mutations of the MT2 is associated with a six times increased risk of developing type 2 diabetes.
Read/learn more at Yahoo News.
Want to read more articles like this one? Subscribe to EURnewsletter.
Got A News Tip or Video You Want to Share? Contact us HERE.
- Fans Blast Nicki Minaj's Narcissistic Reaction to Zendaya’s Barbie
- Kanye Performing at DNC Fundraiser, Kim Expecting Son on Christmas Day
- AARP: American Association of...'Real Possibilities???'
- Zoe Saldana Inks Deal to Create Digital Shows for Millennial Mothers
- This Landlord Will Only Rent To Tenants With Pit Bulls
- Warren Sapp Pleads Guilty to Domestic Violence, Avoids Jail
- Man Sentenced to 20 Years in One Court, Then Leaves to Marry Girlfriend in Another
- Joseph Patterson Convicted in Death of Adrian Peterson's Son
- 'Family Feud': Sexually Provocative Q&As Have Viewers Alarmed (WATCH)
- Amber Rose's 'SlutWalk': Several Hundred Showed Up (VIDEO/PHOTOS)
- Discover More Stories on EURweb: Click Here